Hutch News

Hutch News

Stories tagged 'Cord Blood Program'

Good News at Fred Hutch

Celebrating faculty and staff achievements

Aug. 17, 2017

Dr. Filippo Milano and colleagues in the Cord Blood Program at Fred Hutch have received funding from the Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation to support a clinical trial to improve the use of umbilical cord blood as a treatment for leukemia ... and more good news at Fred Hutch.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

April 13, 2017

GeekWire Award finalists include Bezos Family Immunotherapy Clinic and Nohla Therapeutics, among others; Scientists read infection history in immune genes; and two Hutch faculty members in final class of Kimmel Scholars.

View story >


For high-risk leukemia patients, umbilical cord blood transplant associated with lower risk of relapse

Study compares ‘alternative’ donor source vs. traditional transplantation of blood stem cells from an adult, unrelated donor

Sept. 7, 2016 | By Rachel Tompa / Fred Hutch News Service

A new study by Fred Hutch researchers, published today in The New England Journal of Medicine, has found that umbilical cord blood transplants may have advantages beyond being an alternative source of stem cells for patients without a traditional donor match. They also are associated with a lower risk of relapse in high-risk leukemia patients.

View story >


Good News at Fred Hutch

Celebrating faculty and staff achievements

July 8, 2016

Dr. Colleen Delaney leads first test of "off-the-shelf" cord blood cell product outside the transplant setting; Dr. Justin Taylor receives Hartwell Foundation award to research alternative to RSV vaccine

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.